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A 61-year-old Japanese man with IgG4-related autoimmune pancreatitis was referred to our hospital 
because of perspiration during food intake.  Abdominal computed tomography (CT) with contrast 
media revealed multiple mesenteric lymphadenopathies.  An open surgical abdominal biopsy and subse-
quent histopathological analysis revealed abnormally large lymphoid cells that were negative for CD3,  
CD5,  and c-myc and positive for CD20 and bcl-2,  leading to a diagnosis of diﬀuse large B-cell lym-
phoma.  Here,  we discuss the risk of malignancies,  particularly malignant lymphoma in patients with 
IgG4-related disease.  The importance of pathological analysis to reach the appropriate diagnosis in 
such cases should be emphasized.
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I gG4-related disease (IgG4-RD) is a clinical entity established within the last decade.  It is charac-
terized by tumor-like lesions,  ﬁbrosis,  and lympho-
plasmacytic inﬁltration to virtually every organ,  
including the pancreas,  salivary glands,  kidneys,  
breasts,  and aorta ﹇1-3﹈.  Elevated serum concentra-
tions of IgG4 and glucocorticoid responsiveness have 
been considered important for proper diagnosis ﹇4﹈.  
Though the pathogenesis of IgG4-RD is still poorly 
understood ﹇5﹈,  an association between IgG4-RD and 
malignant tumors has been suggested ﹇6,  7﹈.  Herein,  
we describe a rare complication of diﬀuse large B-cell 
lymphoma (DLBCL) in a patient with IgG4-related 
autoimmune pancreatitis.
Case Report
　 A 61-year-old Japanese man with IgG4-related 
autoimmune pancreatitis (AIP) was referred to our 
hospital because of perspiration upon food intake.  The 
perspiration was noted immediately during food intake 
and had been progressively getting worse.  He had 
been diagnosed with AIP 3 years earlier.  His serum 
IgG at his ﬁrst visit to his primary doctor was 
2,288mg/dL,  serum IgG4 549.0mg/dL,  and CRP 
0.11mg/dL.  Abdominal CT at his ﬁrst visit with his 
primary doctor revealed enlargement of the pancreatic 
head and narrowing of the main pancreatic duct and 
proximal bile duct.  Endoscopic retrograde cholangio-
pancreatography (ERCP) conﬁrmed the ﬁnding noted 
on the CT.  After the initiation of steroid therapy,  the 
bile duct narrowing improved.  These ﬁndings led to a 
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possible diagnosis of AIP.  Subsequently,  he had no 
fever,  chills,  or night sweats,  but after 3 months he 
reported 10kg weight loss.  He had a history of diabe-
tes mellitus and a gastric resection due to advanced 
gastric cancer.
　 A blood test on the day of admission revealed 
increased levels of serum IgG4 (596mg/dl; reference 
range 4.8-105.0mg/dl) and soluble interleukin-2 
receptor (sIL-2R; 704U/ml; reference range 122-
496U/ml).  Test results are shown in Table 1.  A sec-
ond abdominal CT with contrast media after admission 
revealed focal pancreatic enlargement and dilatation of 
the main pancreatic duct (Fig.  1A),  multiple mesenteric 
lymphadenopathies (Fig.  1B),  and no hepatic lesions 
(Fig.  1C).  In addition,  18F-ﬂuorodeoxyglucose posi-
tron emission tomography/CT (FDG-PET/CT) 
revealed diﬀuse involvement of the para-aortic and 
mesenteric lymph nodes (Fig.  1E).  To further inves-
tigate the cause of the lymphadenopathy,  an open 
surgical abdominal biopsy for the mesenteric lymph 
nodes was performed.  During the surgery,  a tumor-
like lesion in the ileum was incidentally found and 
subsequently resected for pathological analysis (Fig.  
2A).  Flow cytometry of the mesenteric lymph node 
revealed an abnormal population of CD10-positive and 
CD20-positive lymphocytes.  Histopathological analy-
sis revealed diﬀuse proliferation of large atypical 
lymphoid cells and eﬀacement of the normal lymph 
node architecture (Fig.  2B).  Immunostaining showed 
that those lymphoid cells were negative for CD3,  
CD5,  and c-myc and positive for CD10,  CD20,  and 
bcl-2 (Fig.  2C-E).  Accordingly,  a diagnosis of 
DLBCL was made.  Contrast-enhanced CT of the liver 
performed 3 weeks after admission showed multiple 
hepatic lesions,  suggesting a need for emergent treat-
ment (Fig.  1D).  Bone marrow aspiration and biopsy 
revealed no lymphoma inﬁltration.  Consequently,  the 
patient was diagnosed with DLBCL involving the ileum 
and liver.  The clinical stage was considered stage IV.  
He was subsequently treated with rituximab plus 
cyclophosphamide,  doxorubicin,  vincristine,  and 
prednisone (R-CHOP).  After 2 courses of this treat-
ment,  substantial reductions in hepatic lesions and 
lymphadenopathies were noted.
Discussion
　IgG4-RD frequently involves the lymph nodes,  and 
tumefactive lesions typically characterize the disease.  
These lesions sometimes mimic malignancies,  posing a 
diagnostic challenge ﹇8,  9﹈.  With regard to tumori-
genesis,  the increased risk of development of malig-
nant tumors in patients with IgG4-RD has been con-
troversial ﹇7,  10,  11﹈.  Hirano et al.  reported that the 
risk of malignant tumors in patients with IgG4-RD is 
similar to that of the general population ﹇10﹈.  On the 
contrary,  a Japanese retrospective study revealed a 
383.0 standardized incidence ratio (SIR) for malignan-
cies in patients with IgG4-RD,  
which is strikingly higher than 
that of the general population 
﹇7﹈.  Malignancies that have 
been reported as complications 
include non-Hodgkin lymphoma,  
including extranodal marginal 
zone B-cell lymphoma of the 
mucosa-associated lymphoid tis-
sue type (MALT lymphoma),  as 
well as non-lymphoid tumors 
such as breast,  colorectal,  lung,  
renal,  and prostate carcinoma 
﹇7﹈.  According to Takahashi et 
al.,  in IgG4-RD the SIR for 
malignant lymphoma is 16.0-
fold higher than in the general 
population ﹇12﹈.  They exam-
ined 111 IgG4-related autoim-
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Table 1　 Laboratory data
Variable Reference range On admission On discharge
Blood
Hematocrit (%) 40.7-50.1 38.4 24.7
Hemoglobin (%) 13.7-16.8 12.7 8.1
White-cell count (/mm3) 3,300-8,600 5,920 4,300
Platelet (/mm3) 158-348×103 211×103 152×103
Sodium (mEq/L) 138-145 134 139
Potassium (mEq/L) 3.6-4.8 4.2 3.7
Chloride (mEq/L) 101-108 101 106
Calcium (mg/dL) 8.8-10.1 7.8 8.0
Magnesium (mg/dL) 2.0-2.5 1.8 1.8
HbA1c (%) 4.9-6.0 7.1 5.7
LDH (U/L) 124-222 298 149
Soluble IL2-R (U/mL) 122-496 704 1,268
IgG4 (mg/dL) 4.8-105 596 178
IgG (mg/dL) 861-1,747 2,483.6 1,129.1
IgA (mg/dL) 93-393 476.8 265.1
IgM (mg/dL) 33-183 119.8 55.9
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Fig.  1　 Radiological ﬁndings of IgG4-related pancreatitis and malignant lymphoma.  Contrast-enhanced abdominal computed tomography 
(CT) upon admission revealed focal pancreatic enlargement and dilatation of the main pancreatic duct (A).  There were multiple mesenteric 
lymphadenopathies (B).  No hepatic space-occupying lesions (SOL) were observed at the time (C).  Contrast-enhanced CT of the liver 
performed 3 weeks after admission showed multiple hepatic lesions,  suggesting rapid progression of the disease (D).  18F-ﬂudeoxyglucose 
positron emission tomography/CT revealed diﬀuse involvement of para-aortic and mesenteric lymph nodes (E).
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Fig. 2　 Pathological ﬁndings of mesenteric lymph nodes.  A tumefactive lesion in the ileum was incidentally found during an open surgi-
cal biopsy of the mesenteric lymph nodes (A).  The mass was resected for pathological analysis,  revealing diﬀuse proliferation of large 
atypical lymphoid cells exhibiting eﬀacement of the normal lymph node architecture (B).  Immunopathological staining showed that those 
lymphoid cells were negative for CD3,  CD5,  and c-myc and positive for CD10 (C),  CD20 (D),  and bcl-2 (E).  These immunopathological 
ﬁndings led to the ﬁnal diagnosis of DLBCL.  
mune pancreatitis patients,  of whom 3 developed non-
Hodgkin lymphoma with extranodal involvement during 
the follow-up period.  Development of anaplastic large 
cell lymphoma in a patient with IgG4-RD autoimmune 
pancreatitis,  cholecystitis,  and a history of DLBCL 
has also been reported ﹇13﹈.  Other reports suggest 
that IgG4-producing lymphoma,  marginal zone B-cell 
lymphoma,  and mantle cell lymphoma may develop 
﹇14,  15﹈.  MALT lymphoma is a common subtype of 
non-Hodgkin lymphoma that can be complicated with 
IgG4-RD ﹇14,  16﹈.  To date,  however,  only a few 
reports have described the development of malignant 
lymphoma in a patient with IgG4-RD.  Characteristics 
of previous cases as well as the present one are sum-
marized in Table 2.  Our patient,  who had IgG4-
related autoimmune pancreatitis without any other 
extraglandular involvement,  developed DLBCL during 
the follow-up period for IgG4-related autoimmune 
pancreatitis,  which is a rare complication.  Thus,  the 
diﬀerentiation of IgG4-RD and malignant lymphoma is 
of clinical importance,  as there is a reported possibil-
ity of the development of malignant lymphoma based on 
IgG4-RD.  Chronic inﬂammation is a known predis-
posing factor for the development of malignant lym-
phoma ﹇17,  18﹈.  Based on previous case reports,  we 
speculate that chronic inﬂammation due to IgG4-RD 
predisposes patients to develop malignant lymphoma.  
As increased secretion of Th2 cytokines such as inter-
leukin-4,  5,  10,  and 13,  which activate B-cells ﹇19﹈,  
is implicated in the pathogenesis of IgG4-RD,  the 
predominance of B-cell lymphoma as a secondary 
development to IgG4-RD is plausible.
　 In the present case,  the patient visited our hospital 
because of progressive perspiration; this unusual 
complaint may have several possible causes,  such as 
dumping syndrome due to his history of gastric resec-
tion or malignant lymphoma.  Perspiration itself is 
suggestive of a B symptom of malignant lymphoma,  
but the relationship between food intake and perspira-
tion is unclear.  However,  since the abdominal CT at 
the time of admission revealed multiple mesenteric 
lymphadenopathies,  a complication of malignant lym-
phoma was highly suspected.  An immediate open 
abdominal biopsy and the following pathological analy-
sis were the most crucial steps in determining a 
deﬁnitive diagnosis and treatment plan.  Currently,  
biopsy is strongly recommended as the most important 
diagnostic procedure ﹇4﹈.  We performed IgG and 
IgG4 immunostaining for the mesenteric lymph nodes 
(Fig.  3A-B).  Since the IgG/IgG4 ratio was less than 
40  in the lesion,  DLBCL was thought to be the 
mainstay of the patientʼs clinical condition.  However,  
as IgG4-positive cells were recognized in the lesion,  
it is still probable that IgG4-RD is related to the 
tumorigenesis of DLBCL.  Since only a few cases have 
been reported regarding the pathophysiology of 
DLBCL in patients with IgG4-RD,  it will be essential 
to accumulate more cases for further analysis.
　 In conclusion,  even though there is no current 
consensus regarding the risk of malignancies in 
patients with IgG4-RD as described above,  our case 
emphasizes the importance of pathological evaluation 
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Table 2　 Features of malignant lymphoma in patients with IgG4-RD
Case
No. Author Age/Sex Primary IgG4-RD Type of ML Characteristics
1 Takahashi ﹇12﹈ 65/F AIP BCL (liver) BCL developed 4 years after the diagnosis of AIP
2 Takahashi ﹇12﹈ 72/M AIP DLBCL
(adrenal)
DLBCL developed 5 years after the diagnosis of AIP
3 Takahashi ﹇12﹈ 69/M Chronic parotitis DLBCL
(kidney)
DLBCL developed 3 years after the diagnosis of 
chronic parotitis
4 Ishida ﹇13﹈ 61/M AIP,  IgG4-related 
cholecystitis
DLBCL IgG4-RDs occurred 5 years after DLBCL. ALCL was 
found a year after the diagnosis of IgG4-RDs 
6 Mulay ﹇15﹈ 65/F Dacryoadenitis EMZL Concurrent IgG4-related dacryoadenitis and EMZL, 
presenting with bilateral upper eyelid swelling
7 This case 61/M AIP DLBCL DLBCL developed 4 years after the diagnosis of AIP, 
presenting with progressive perspiration
IgG4-RD,  IgG4-related disease; ML,  malignant lymphoma; AIP,  autoimmune pancreatitis; BCL,  B-cell lymphoma; DLBCL,  diﬀuse large 
B-cell lymphoma; ALCL,  anaplastic large cell lymphoma; EMZL,  extranodal marginal zone B-cell lymphoma.
to correctly detect malignant lymphoma in IgG4-RD 
patients,  in addition to thorough history-taking and 
laboratory examinations.
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Fig. 3　 IgG/IgG4 immunostaining of mesenteric lymph nodes.
Immunostaining for IgG and IgG4 was performed on mesenteric 
lymph nodes.  Numerous cells were positive for IgG immunostaining 
(A).  Although the IgG/IgG4 ratio was less than 40%,  a consider-
able proportion of cells were still positive for IgG4 (B).  
